Hepatitis E virus infection in patients infected with the human immunodeficiency virus

Journal of Medical Virology

Volumn 83, Issue 10, 2011, Pages 1704-1716

  Kaba, Mamadou ^a,b   Richet, Hervé ^a,b   Ravaux, Isabelle ^c   Moreau, Jacques ^d   Poizot Martin, Isabelle ^e   Motte, Anne ^a   Nicolino Brunet, Corinne ^c   Dignat George, Françoise ^c   Ménard, Amélie ^e   Dhiver, Catherine ^c   Brouqui, Philippe ^b,d   Colson, Philippe ^a,b  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d HÔPITAL NORD   (France)

^e HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Autochthonous transmission; Chronic HEV infection; France; Hepatitis E virus; Human immunodeficiency virus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DISEASE ASSOCIATION; FEMALE; FRANCE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RNA ANALYSIS; SEROLOGY; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FRANCE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, RNA;

HEPATITIS E VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80051582582     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22177     Document Type: Article

References (75)

1. Atiq M, Shire NJ, Barrett A, Rouster SD, Sherman KE, Shata MT. 2009. Hepatitis E virus antibodies in patients with chronic liver disease. Emerg Infect Dis 15: 479-481.
2. Balayan MS, Fedorova OE, Mikhailov MI, Rytick PG, Eremin VF, Danilova TI, Shevelev BI, Gorbacheva EC, Pankova GY. 1997. Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients. J Viral Hepat 4: 279-283.
3. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 80: 95-101.
4. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. 2010. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 82: 799-805.
5. Bissuel F, Houhou N, Leport C, Brun-Vezinet F, Vildé JL. 1996. Hepatitis E antibodies and HIV status. Lancet 347: 1494.
6. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F. 2008. Persistent arthralgia associated with chikungunya virus: A study of 88 adult patients on reunion island. Clin Infect Dis 47: 469-475.
7. Boutrouille A, Bakkali-Kassimi L, Crucière C, Pavio N. 2007. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 45: 2009-2010.
8. Bouwknegt M, Engel B, Herremans MM, Widdowson MA, Worm HC, Koopmans MP, Frankena K, de Roda Husman AM, De Jong MC, Van Der Poel WH. 2008. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands. Epidemiol Infect 136: 567-576.
9. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, Teo CG. 2006. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 16: 79-83.
10. Buti M, Jardí R, Cotrina M, Rodríguez-Frías F, Troonen H, Viladomiu L, Esteban JI, Esteban R, Guardia J. 1995. Hepatitis E virus infection in acute hepatitis in Spain. J Virol Methods 55: 49-54.
11. Chamie G, Bonacini M, Bangsberg DR, Stapleton JT, Hall C, Overton ET, Scherzer R, Tien PC. 2007. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 44: 577-583.
12. Chen DS, Sung JL. 1985. Persistence of IgM hepatitis A antibody after clinical type A hepatitis. Hepatology 5: 705.
13. Christensen PB, Engle RE, Jacobsen SE, Krarup HB, Georgsen J, Purcell RH. 2002. High prevalence of hepatitis E antibodies among Danish prisoners and drug users. J Med Virol 66: 49-55.
14. Ciesek S, Helfritz FA, Lehmann U, Becker T, Strassburg CP, Neipp M, Ciner A, Fytili P, Tillmann HL, Manns MP, Wedemeyer H. 2008. Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver. J Infect Dis 197: 355-360.
15. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. 2007. Transfusion-associated hepatitis E, France. Emerg Infect Dis 13: 648-649.
16. Colson P, Dhiver C, Gérolami R. 2008. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin Microbiol Infect 4: 1176-1180.
17. Colson P, Kaba M, Moreau J, Brouqui P. 2009. Hepatitis E in an HIV-infected patient. J Clin Virol 45: 269-271.
18. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, Raoult D, Gerolami R. 2010a. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 202: 825-834.
19. Colson P, Gérolami R, Moreau J, Borentain P, Brouqui P. 2010b. Concurrent autochthonous acute hepatitis E and hepatitis B reverse seroconversion in an HIV-1-infected patient: One virus may hide another. Int J Infect Dis 14: e357.
20. Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gérolami R. 2011. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat 18: 227-228.
21. Curry JA, Adams N, Crum-Cianflone NF. 2009. Acute hepatitis E virus infection in an HIV-infected person in the United States. Ann Intern Med 150: 226-227.
22. Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. 2007. Locally acquired hepatitis E in chronic liver disease. Lancet 369: 1260.
23. Dalton HR, Bendall R, Ijaz S, Banks M. 2008. Hepatitis E: An emerging infection in developed countries. Lancet Infect Dis 8: 698-709.
24. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. 2009. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 361: 1025-1027.
25. Drobeniuc J, Meng J, Reuter G, Greene-Montfort T, Khudyakova N, Dimitrova Z, Kamili S, Teo CG. 2010. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: Pangenotypic evaluation of performances. Clin Infect Dis 51: e24-e27.
26. Erker JC, Desai SM, Mushahwar IK. 1999. Rapid detection of Hepatitis E virus RNA by reverse transcription-polymerase chain reaction using universal oligonucleotide primers. J Virol Methods 81: 109-113.
27. Fainboim H, González J, Fassio E, Martínez A, Otegui L, Eposto M, Cahn P, Marino R, Landeira G, Suaya G, Gancedo E, Castro R, Brajterman L, Laplumé H. 1999. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 6: 53-57.
28. Favorov MO, Khudyakov YE, Mast EE, Yashina TL, Shapiro CN, Khudyakova NS, Jue DL, Onischenko GG, Margolis HS, Fields HA. 1996. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J Med Virol 50: 50-58.
29. Gérolami R, Moal V, Colson P. 2008. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 358: 859-860.
30. Gérolami R, Moal V, Picard C, Colson P. 2009. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 50: 622-624.
31. Gessoni G, Manoni F. 1996. Hepatitis E virus infection in north-east Italy: Serological study in the open population and groups at risk. J Viral Hepat 3: 197-202.
32. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, Koopmans MP. 2008. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 14: 547-553.
33. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, Reimerink JH, Koopmans MP. 2009. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 15: 1225-1228.
34. Kaba M, Davoust B, Marié JL, Barthet M, Henry M, Tamalet C, Raoult D, Colson P. 2009. Frequent transmission of hepatitis E virus among piglets in farms in Southern France. J Med Virol 81: 1750-1759.
35. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L. 2008. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358: 811-817.
36. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssière L, Cointault O, Ribes D, Cardeau I, Nogier MB, Mansuy JM, Muscari F, Peron JM, Izopet J, Rostaing L. 2010. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 89: 353-360.
37. Kenfak-Foguena A, Schöni-Affolter F, Bürgisser P, Witteck A, Darling KEA, Kovari H, Kaiser L, Evison JM, Elzi L, Gurtner-De La Fuente V, Jost J, Moradpour D, Abravanel F, Izopet J, Cavassini M, the Swiss HIV Cohort Study. 2011. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 17: 1074-1078.
38. Khuroo MS. 1980. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 68: 818-824.
39. Kumar AS, Kumar SP, Singh R, Kumar MS, Madan K, Kumar JJ, Kumar PS. 2007. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 46: 387-394.
40. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. 2009. Epidemiology of hepatitis E virus in the United States: Results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 200: 48-56.
41. Legrand-Abravanel F, Mansuy JM, Dubois M, Kamar N, Peron JM, Rostaing L, Izopet J. 2009a. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 15: 110-114.
42. Legrand-Abravanel F, Thevenet I, Mansuy JM, Saune K, Vischi F, Peron JM, Kamar N, Rostaing L, Izopet J. 2009b. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 16: 772-774.
43. Lewis HC, Wichmann O, Duizer E. 2010. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: A systematic review. Epidemiol Infect 138: 145-166.
44. Li TC, Zhang J, Shinzawa H, Ishibashi M, Sata M, Mast EE, Kim K, Miyamura T, Takeda N. 2000. Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J Med Virol 62: 327-333.
45. Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, Kurata Y, Ishida M, Sakamoto S, Takeda N, Miyamura T. 2005. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 11: 1958-1960.
46. Lu L, Li C, Hagedorn CH. 2006. Phylogenetic analysis of global hepatitis E virus sequences: Genetic diversity, subtypes and zoonosis. Rev Med Virol 16: 5-36.
47. Madejón A, Vispo E, Bottecchia M, Sánchez-Carrillo M, García-Samaniego J, Soriano V. 2009. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 16: 895-896.
48. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, Rech H, Destruel F, Izopet J. 2008. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 80: 289-293.
49. Mast EE, Alter MJ, Holland PV, Purcell RH. 1998. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 27: 857-861.
50. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, Sato S, Kato T, Nishimori H, Tsuji K, Maguchi H, Yoshida J, Maekubo H, Mishiro S, Ikeda H. 2008. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 48: 1368-1375.
51. Medrano FJ, Sanchez-Quijano A, Torronteras R, Leal M, Lissen E. 1995. Hepatitis E virus and HIV infection in homosexual men. Lancet 345: 127.
52. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. 2002. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 40: 117-122.
53. Moal V, Motte A, Vacher-Coponat H, Gérolami R, Tamalet C, Berland Y, Colson P. 2008. Strong decrease of anti-hepatitis B surface antigen antibodies following renal transplantation. J Hepatol 48: S255-S256.
54. Montella F, Rezza G, Di Sora F, Pezzotti P, Recchia O. 1994. Association between hepatitis E virus and HIV infection in homosexual men. Lancet 344: 1433.
55. Nandwani R. 1995. Hepatitis E virus and HIV infection in homosexual men. Lancet 345: 126-127.
56. Ng KP, He J, Saw TL, Lyles CM. 2000. A seroprevalence study of viral hepatitis E infection in human immunodeficiency virus type 1 infected subjects in Malaysia. Med J Malaysia 55: 58-64.
57. Okamoto H, Takahashi M, Nishizawa T. 2003. Features of hepatitis E virus infection in Japan. Intern Med 42: 1065-1071.
58. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, Nicand E. 2009. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 150: 430-431.
59. Péron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, Dupuis E, Izopet J, Vinel JP. 2007. Fulminant liver failure from acute autochthonous hepatitis E in France: Description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 14: 298-303.
60. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J, Strassburg CP, Lehner F, Raupach R, Bremer B, Magerstedt P, Cornberg M, Seehusen F, Baumgaertner W, Klempnauer J, Izopet J, Manns MP, Grummer B, Wedemeyer H. 2010a. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 16: 74-82.
61. Pischke S, Ho H, Urbanek F, Meyer-Olsen D, Suneetha PV, Manns MP, Stoll M, Wedemeyer H. 2010b. Hepatitis E in HIV-positive patients in a low-endemic country. J Viral Hepat 17: 598-599.
62. Psichogiou MA, Tassopoulos NC, Papatheodoridis GV, Tzala E, Klarmann R, Witteler H, Schlauder GG, Troonen H, Hatzakis A. 1995. Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis. J Hepatol 23: 668-673.
63. Purcell RH, Emerson SU. 2008. Hepatitis E: An emerging awareness of an old disease. J Hepatol 48: 494-503.
64. Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allègre T, Poggi C, Pénaranda G, Cordier F, Nicand E, ANGH. 2010. Hepatitis E virus in HIV-infected patients. AIDS 24: 1493-1499.
65. Sellier P, Mazeron MC, Tesse S, Badsi E, Evans J, Magnier JD, Sanson-le-Pors MJ, Bergmann JF, Nicand E. 2011. Hepatitis E Virus infection in HIV-infected patients with elevated serum transaminases levels. Virol J 8: 171.
66. Sylvan SP. 1998. The high rate of antibodies to hepatitis E virus in young, intravenous drug-abusers with acute hepatitis B-virus infection in a Swedish community: A study of hepatitis markers in individuals with intravenously or sexually acquired hepatitis B-virus infection. Scand J Infect Dis 30: 429-430.
67. Takahashi M, Kusakai S, Mizuo H, Suzuki K, Fujimura K, Masuko K, Sugai Y, Aikawa T, Nishizawa T, Okamoto H. 2005. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 43: 49-56.
68. Tamura K, Dudley J, Nei M, Kumar S. 2007a. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
69. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, Mishiro S, Shimizu K, Moriyama M. 2007b. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 37: 113-120.
70. Tappe D, Müller A, Ziegler U, Weissbrich B, Schubert J, Günther S, Schmidt-Chanasit J, Stich A. 2010. Positive hepatitis E and Epstein Barr virus serology in a patient with jaundice after travel. J Clin Virol 48: 78-81.
71. Thoden J, Venhoff N, Miehle N, Klar M, Huzly D, Panther E, Jilg N, Kunze M, Warnatz K. 2008. Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS 22: 909-910.
72. Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, Purcell RH. 1997. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 35: 1244-1247.
73. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The CLUSTAL-X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-4882.
74. Tran A, Broussard JF, Durant J, Broussard N, Dellamonica P, Rampal P, Benzaken S. 1997. Prevalence of serum anti-hepatitis E virus antibodies in patients with human immunodeficiency virus infection. Gastroenterol Clin Biol 21: 440.
75. Trinta KS, Liberto MI, de Paula VS, Yoshida CF, Gaspar AM. 2001. Hepatitis E virus infection in selected Brazilian populations. Mem Inst Oswaldo Cruz 96: 25-229.